Apollo Hospitals Q4 profit falls

Apollo Hospitals Q4 profit falls

Shares of Apollo Hospitals was trading 2% lower in the morning session on June 24, a day after the company reported a fall in consolidated net profit at Rs 169.89 crore for the fourth quarter ended March 31, 2021.
The company had posted a consolidated net profit of Rs 209.60 crore in the corresponding quarter of the previous fiscal. Consolidated revenue from operations stood at Rs 2,867.95 crore in against Rs 2,922.43 crore in the year-ago quarter.
For the fiscal ended March 31, 2021, its consolidated net profit stood at Rs 136.77 crore. It was at Rs 431.80 crore in FY20.

Consolidated revenue from operations for FY21 was at Rs 10,560.01 crore. It was at Rs 11,246.80 crore in FY20.
Meanwhile, India’s biggest healthcare company also announced the launch of country’s “largest omni-channel digital health platform” by merging its online, offline pharmacy and tele-medicine verticals into a single entity called Apollo HealthCo.

Apollo transferred its back-end offline pharmacy business (excluding hospital-based pharmacies), digital healthcare platform Apollo 24/7, its investment in retail pharmacy business (Apollo Medicals Private Ltd), and the “Apollo 24/7” brand, the “Apollo Pharmacy” brand and private label brands into the healthcare group’s 100 percent subsidiary Apollo HealthCo Limited.
This platform will combine the strengths of Apollo Group’s offline healthcare leadership with Apollo Group’s new-age digital offerings to address all healthcare consumer needs.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.